Aly-Khan Lalani, MD of Dana-Farber Cancer Institute gives an overview of practice-changing data coming out of ASCO on metastatic hormone-sensitive prostate cancer. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.
Annual Meeting 2017: Practice-Changing Studies on Metastatic Hormone-Sensitive Prostate Cancer
